PAHC
NASDAQ · Pharmaceuticals
Phibro Animal Health Corp-A
$31.85
+1.01 (+3.28%)
Financial Highlights (FY 2026)
Revenue
1.31B
Net Income
48.62M
Gross Margin
31.6%
Profit Margin
3.7%
Rev Growth
+11.2%
D/E Ratio
2.52
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 31.6% | 31.6% | 36.7% | 36.7% |
| Operating Margin | 8.5% | 7.7% | 35.4% | 32.2% |
| Profit Margin | 3.7% | 3.5% | 25.7% | 26.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 1.31B | 1.17B | 1.31B | 972.76M |
| Gross Profit | 412.48M | 370.90M | 479.67M | 357.06M |
| Operating Income | 111.25M | 90.03M | 462.06M | 312.99M |
| Net Income | 48.62M | 39.35M | 335.32M | 253.19M |
| Gross Margin | 31.6% | 31.6% | 36.7% | 36.7% |
| Operating Margin | 8.5% | 7.7% | 35.4% | 32.2% |
| Profit Margin | 3.7% | 3.5% | 25.7% | 26.0% |
| Rev Growth | +11.2% | +11.2% | +2.9% | -6.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 462.25M | 462.25M | 399.08M | 413.63M |
| Total Equity | 183.75M | 183.75M | 1.04B | 1.11B |
| D/E Ratio | 2.52 | 2.52 | 0.38 | 0.37 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 157.21M | 134.30M | 482.41M | 394.81M |
| Free Cash Flow | — | — | 282.39M | 183.99M |